Tempus AI Imaging vs Ultromics EchoGo
Tempus Pixel goes to a health system's radiology and oncology readers, and Ultromics goes to a cardiology group with an echo lab. The Tempus radiology page describes lesion segmentation, RECIST-style response reports and cardiac MR analysis. Its footnote adds that Pixel Lung is cleared under K203744 but is not indicated for lung nodule detection, which comes from third-party engines in the US. Ultromics reads echocardiography. EchoGo Heart Failure was cleared in K222463 on November 23, 2022 as a diagnostic aid for HFpEF from one apical four-chamber view. A 2026 JACC Heart Failure analysis of EchoGo HF in the MESA cohort (N=2,544) reports an AUROC of 0.77 for early HFpEF against 0.70 for the H2FPEF score. MR and oncology CT reading on one side and echo on the other are different modalities in different departments. A hospital with a cardiac MR program in radiology and an echo lab in cardiology would buy each for its own studies.
Radiology · Reviewed November 2, 2026
Tempus AI Imaging
by Tempus AI
Tempus Pixel (formerly Arterys): cloud imaging AI for radiology and oncology reads, with cardiac MR, lung, breast and prostate tools.

Ultromics EchoGo
by Ultromics
FDA-cleared AI on echocardiograms that flags heart failure with preserved ejection fraction and screens for cardiac amyloidosis.
When to pick each one
Tempus AI Imaging
- Tempus page lists RECIST-style response reports
- Tempus lists T1 and T2 inline maps from raw cardiac MR
- openFDA lists K252539, filed by Arterys, Inc., September 3, 2025
Ultromics EchoGo
- Vendor cites 90.3% sensitivity, 86.1% specificity, EchoGo HF 2.0
- Vendor says findings return to PACS and EMR
Score
Each row shows points earned of points available under the published rubric.
Tempus AI Imaging
32of 100
Ultromics EchoGo
42of 100
| Dimension | Tempus AI Imaging | Ultromics EchoGo | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 6 / 10 | -6 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 0 / 18.2 | 0 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 6 / 12 | 8.4 / 12 | -2.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Tempus AI Imaging
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Ultromics EchoGo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Tempus AI Imaging
FDA decisions
K252539 (opens in new tab)510(k)2025-09-03
Tempus Pixel (applicant Arterys, Inc.)
K203744 (opens in new tab)510(k)2022-03-14
Arterys MICA (applicant Arterys, Inc.)
K192437 (opens in new tab)510(k)2020-03-25
Arterys MICA (applicant Arterys, Inc.)
K182034 (opens in new tab)510(k)2018-10-17
Arterys MICA (applicant Arterys, Inc.)
K173542 (opens in new tab)510(k)2018-01-25
Arterys Oncology DL (applicant Arterys, Inc.)
Show 3 more
K171544 (opens in new tab)510(k)2017-07-18
Arterys Viewer (applicant Arterys, Inc.)
K163253 (opens in new tab)510(k)2017-01-05
Arterys Cardio DL (applicant Arterys, Inc.)
K162513 (opens in new tab)510(k)2016-10-28
Arterys Software v2.0 (applicant Arterys, Inc.)
Ultromics EchoGo
FDA decisions
K240860 (opens in new tab)510(k)2024-11-15
EchoGo Amyloidosis (1.0)
K240013 (opens in new tab)510(k)2024-09-23
EchoGo Heart Failure (2.0)
K222463 (opens in new tab)510(k)2022-11-23
EchoGo Heart Failure 1.0
K213275 (opens in new tab)510(k)2021-12-20
EchoGo Core (2.0)
K201555 (opens in new tab)510(k)2020-12-18
EchoGo Pro v1.0.2
Show 1 more
K191171 (opens in new tab)510(k)2019-11-13
EchoGo Core
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Tempus AI Imaging | Ultromics EchoGo |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | US | GB |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.
